Keith Delman retweeted
New weekly @AnnSurgOncol featured article: Short-term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at a High Risk for Breast Cancer: A Systematic Review.
ow.ly/3Lwi50VCXJG #ASOFeaturedArticle
Keith Delman retweeted
👏👏👏
Honored to present our work on gender and seniority bias in surgical resident evaluations at #ASE2025. Grateful for the chance to engage with such a thoughtful and inspiring community @EmorySurgery @Surg_Education
Keith Delman retweeted
#AudioVisualAbstract : Results of a Randomized Clinical Study of #Gemcitabine Plus Nab-Paclitaxel Versus Gemcitabine Plus S-1 as Neoadjuvant Chemotherapy for Resectable and Borderline Resectable #Pancreatic #DuctalAdenocarcinoma
rdcu.be/eloqh
@SyedAAhmad5
Keith Delman retweeted
May Issue: Identification of Predictive Factors for the Development of In-Transit Metastasis in Patients with #Melanoma . @OlofssonBagge @C_ODonoghueMD @alabama_surgonc @MarkFariesMD @jzager99
rdcu.be/ekVZg
@DorianGarciaMD
@SyedAAhmad5
Keith Delman retweeted
#AudioVisualAbstract : Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive #BreastCancer : A Retrospective Analysis
rdcu.be/ek3b4
@belenmerck
@SyedAAhmad5
Keith Delman retweeted
May Issue: Clinical Significance of Coiled-Coil Domain-Containing Protein 25 Expression in #Esophageal #SquamousCellCarcinoma
rdcu.be/ek3eF
@lindSLUe
@SyedAAhmad5
Keith Delman retweeted
Featured: Strategies for Recurrent #ColorectalLiver Metastases Based on Prognostic Factors and Resectability: Potential Benefit of #MultidisciplinaryTreatment . @Kosuke_Koba_yh8
ow.ly/z35w50VON9C
@_BrainyMD_
@SyedAAhmad5
Keith Delman retweeted
#AudioVisualAbstract : Endoscopic Evaluation of #PathologicalCompleteResponse Using #DeepNeuralNetwork in #EsophagealCancer Patients Who Received Neoadjuvant Chemotherapy—Multicenter Retrospective Study from Four Japanese Esophageal Centers
rdcu.be/elfqy
@SyedAAhmad5
Keith Delman retweeted
Thank you for your excellent talks and for sharing your experiences with our residents in rocking chair rounds!
Enjoyed being back in my “home” #BeanTown #Boston as combined @MGHSurgery @MGHCancerCenter Visiting Professor. ❤️seeing old friends & mentors, as well as spending time with next generation of #surgical #leaders. Big 🙏 to Dr. Lillemoe for being as kind & gracious as always. 🎁
Keith Delman retweeted
Join us on April 22, 2025, for the Emory at Grady Faculty Awards. This ceremony will recognize outstanding faculty contributions and achievements. Hope to see you there!279
Keith Delman retweeted
April Issue: Risk-Prediction Models for Clinical Decision-Making in #Sarcoma Care: An International Survey Among Soft-Tissue Sarcoma Clinicians @lvanbodegomvos
rdcu.be/ehSLh
@DorianGarciaMD
@SyedAAhmad5
.@EmoryMedicine @EmoryatGrady @emorygradydoc @grannysurgeon @EmorySurgery This year’s SURG-20 class. Notice something special? Yep! All women. Truly an honor to teach these amazing future doctors @wiserpodcast
Keith Delman retweeted
The latest SSO consensus statement urges caution with gene expression profiling (GEP) for primary cutaneous melanoma. Given evolving evidence, GEP is recommended as an investigational tool in research or clinical trials. Read more: @AnnSurgOncol: surgonc.org/annals-of-surgic…
Keith Delman retweeted
I get asked how GEP tests should be used in cutaneous melanoma at every meeting. Great to see this consensus statement out in print. @SocSurgOnc
The latest SSO consensus statement urges caution with gene expression profiling (GEP) for primary cutaneous melanoma. Given evolving evidence, GEP is recommended as an investigational tool in research or clinical trials. Read more: @AnnSurgOncol: surgonc.org/annals-of-surgic…
Keith Delman retweeted
SSO announces publication of its 1st consensus statement, Assessing the Evidence For and Utility of Gene Expression Profiling of Primary Cutaneous Melanoma. Developed by melanoma specialists around four clinical questions on GEP testing for primary CM. ow.ly/OSAa50TWrhM
.@EmoryMedicine @WinshipAtEmory @GradyHealth @emorygradydoc Marti Russell debating Dr. Jordan Berlin pros and cons of neoadjuvant therapy for pancreas cancer making us proud!! #DDHO2024
Keith Delman retweeted
We are pleased to announce that Oliver Eng, MD, has been selected to serve as new Associate Editor for the Gastrointestinal Surgery section of JSR. Dr. Eng is an Associate Professor of Clinical Surgery in the Division of Surgical Oncology @UCIrvineSurgery.
Keith Delman retweeted
Best job in the 🌎🌍🌏….being a dad to these great kids. Happy #FathersDay2024 to all the dads out there. Hug them twice as hard today! #BlessedAndGrateful
Keith Delman retweeted
Enjoyed celebrating our wonderful Emory General Surgery Chief Residents graduate last night with my friend and mentor @aa_chahine Congrats to all!! @EmorySurgery @EdLinEmory @emorygradydoc @falco__e @JsharmaSharma































